Related Experiment Video
Updated: Dec 26, 2025

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Antiviral Drug Discovery and Development for Mayaro Fever - What do we have so far?
Marcos V P Mello1,2, Thaisa F S Domingos1, Davis F Ferreira3,4
1Laboratory of Molecular Modeling & QSAR (ModMolQSAR), Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Abstract:
Tropical infectious diseases cause millions of deaths every year in developing countries, with about half of the world population living at risk. Mayaro virus (MAYV) is an emerging arbovirus that causes Mayaro fever, which is characterized by fever, headache, diarrhea, arthralgia, and rash. These symptoms can be clinically indistinguishable from other arboviruses, such as Dengue, Zika, and Chikungunya, which makes the diagnosis and treatment of the disease more difficult. Though, the Mayaro virus is a potential candidate to cause large-scale epidemics on the scale of ZIKV and CHIKV. Despite this, there is no licensed vaccine or antiviral for the treatment of Mayaro fever and most arboviruses, so the design and development of candidates for antiviral drugs are urgently needed. In this context, this mini-review aims to provide an overview of studies of anti-MAYV derivatives and highlight the importance of the discovery and development of promising drug candidates for Mayaro fever.
Insights
Mayaro virus (MAYV) causes Mayaro fever, a disease with symptoms similar to Dengue and Zika. New antiviral drugs are urgently needed as no vaccine or treatment currently exists for MAYV.
Area of Science:
- * Tropical infectious diseases and emerging viral threats.
- * Virology and arbovirus research.
- * Drug discovery and development for infectious diseases.
Background:
- * Mayaro virus (MAYV) is an emerging arbovirus responsible for Mayaro fever, prevalent in tropical regions.
- * Mayaro fever symptoms (fever, headache, arthralgia, rash) overlap with other arboviruses like Dengue, Zika, and Chikungunya, complicating diagnosis.
- * MAYV poses a significant threat for large-scale epidemics, similar to Zika virus (ZIKV) and Chikungunya virus (CHIKV).
Purpose of the Study:
- * To review existing studies on anti-MAYV derivatives.
- * To emphasize the critical need for novel antiviral drug candidates against Mayaro fever.
- * To highlight the potential of MAYV as a significant public health concern.
Main Methods:
- * Mini-review of published literature on anti-MAYV research.
- * Analysis of studies focusing on potential antiviral compounds against MAYV.
- * Synthesis of current knowledge on Mayaro fever therapeutics.
Main Results:
- * Limited development of specific antiviral treatments for Mayaro fever.
- * Identification of research gaps in anti-MAYV drug discovery.
- * Highlighting the urgent need for further investigation into antiviral derivatives.
Conclusions:
- * There is a critical lack of licensed vaccines or antiviral treatments for Mayaro fever.
- * The development of effective antiviral drugs against MAYV is urgently required.
- * Further research into anti-MAYV derivatives is essential to combat potential epidemics.
Related Concept Videos
Subviral Agents
Retrovirus Life Cycles
Viruses with RNA Genomes
Retroviruses
Drug Discovery: Overview

